FDA Warns Against Supplements for Erectile Dysfunction
By News Staff
7/18/2006
The products contain some ingredients or analogues of ingredients in drugs the FDA already has approved -- such as sildenafil, the active ingredient in Viagra, or vardenafil, the active ingredient in Levitra -- but the product labels of the so-called supplements do not list these ingredients, says the news release.
Sign Up for FDA E-Mail Alerts
The news release advises consumers to consult a health care professional before purchasing a product to treat ED.
Study Examines U.S. Colorectal Cancer Screening Rates
AHRQ Issues Osteoporosis Treatment Guide
USPSTF Releases New Lipid Screening Recommendations
NRN Studies on Testing Process Errors Published
USPSTF Recommends Universal Newborn Hearing Screening
FDA Licenses Two New Combination Vaccines
ACS Boosts Career Development Awards
AAFP Adopts Rotavirus Vaccine Recommendations
Step Up Influenza Immunization of Asthmatic Patients
Alpha Blockers Can Complicate Cataract Surgery
NIH's ACCORD Trial Publishes Results
FPs Adhere to Asthma Guidelines
FDA Warns of Risks From Antipsychotic Use
Study Suggests Treating High Blood Pressure in Elderly
FDA to Revise Pregnancy Info on Drug Labels
MedWatch E-List Keeps Clinicians Informed
(7/28/2005)
Additional Resources
Recent FDA Warning Letter to Herbal Remedies Web Site
FDA 2004 Talk Paper on Actra-Rx








